CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 05:23 PM EDT
CytomX Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 147.56M | 138.1M | 126.62M | 119.57M | 119.18M | 101.21M | 75.55M | 66.08M | 59.52M | 53.16M | 71.94M | 72.61M | 70.74M | 69.57M | 66.22M | 66.42M | 66.74M |
Cost of Revenue | n/a | n/a | 486K | 1.91M | 3.44M | 4.94M | 5.94M | 6M | 5.92M | 4.43M | 4.42M | 2.94M | 1.48M | 1.48M | n/a | n/a | n/a |
Gross Profit | 147.56M | 138.1M | 126.13M | 117.66M | 115.73M | 96.27M | 69.61M | 60.08M | 53.6M | 48.73M | 67.52M | 69.68M | 69.25M | 68.09M | 66.22M | 66.42M | 66.74M |
Operating Income | 35.96M | 25M | 6.71M | 5.72M | 10.83M | -6.48M | -34.56M | -61.63M | -83.02M | -101.33M | -98.96M | -97.66M | -92.12M | -83.78M | -72.25M | -64.51M | -61.44M |
Interest Income | 5.9M | 7.14M | 8.36M | 9.37M | 9.7M | 9.84M | 8.07M | 5.98M | 3.94M | 1.68M | 1.02M | 473K | 255K | 255K | 288K | 418K | 828K |
Pretax Income | 41.84M | 32.09M | 15.06M | 15.08M | 20.47M | 3.32M | -26.54M | -55.65M | -78.74M | -99.32M | -97.59M | -96.88M | -91.94M | -83.61M | -72.08M | -64.21M | -60.64M |
Net Income | 41.6M | 31.87M | 13.83M | 11.09M | 16.53M | 1.77M | -25.64M | -51.29M | -73.83M | -96.66M | -96.31M | -96.24M | -91.86M | -83.61M | -72.08M | -64.21M | -60.64M |
Selling & General & Admin | 31.4M | 29.73M | 31.93M | 30.79M | 29.8M | 30.02M | 32.26M | 35.94M | 40.28M | 42.85M | 42.24M | 42.83M | 40.48M | 39.16M | 38.85M | 36.4M | 35.69M |
Research & Development | 80.2M | 83.38M | 87.53M | 82.61M | 78.11M | 77.23M | 77.86M | 91.78M | 102.27M | 111.65M | 128.66M | 127.44M | 122.38M | 114.19M | 99.62M | 94.53M | 92.49M |
Other Expenses | n/a | n/a | n/a | -7K | -54K | -39K | -38K | -1K | 342K | 340K | 346K | 303K | -75K | -83K | -118K | -120K | -33K |
Operating Expenses | 111.6M | 113.11M | 119.91M | 113.85M | 108.35M | 107.7M | 110.12M | 127.71M | 142.55M | 154.5M | 170.9M | 170.27M | 162.86M | 153.35M | 138.47M | 130.93M | 128.18M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 111.6M | 113.11M | 119.91M | 113.85M | 108.35M | 107.7M | 110.12M | 127.71M | 142.55M | 154.5M | 170.9M | 170.27M | 162.86M | 153.35M | 138.47M | 130.93M | 128.18M |
Income Tax Expense | 236K | 223K | 1.23M | 3.99M | 3.94M | 1.55M | -891K | -4.36M | -4.92M | -2.66M | -1.36M | -782K | -268K | -255K | -288K | -218K | -174K |
Shares Outstanding (Basic) | 87.12M | 80.1M | 85.09M | 84.88M | 82.03M | 67.31M | 80.73M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 64.53M | 65.06M | 60.97M |
Shares Outstanding (Diluted) | 87.15M | 80.1M | 85.2M | 84.88M | 82.63M | 67.31M | 80.99M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 65.21M | 65.06M | 60.97M |
EPS (Basic) | 0.48 | 0.38 | 0.17 | 0.14 | 0.20 | 0.02 | -0.39 | -0.77 | -1.11 | -1.46 | -1.46 | -1.47 | -1.41 | -1.31 | -1.23 | -1.2 | -1.24 |
EPS (Diluted) | 0.48 | 0.38 | 0.17 | 0.14 | 0.20 | 0.02 | -0.39 | -0.77 | -1.11 | -1.46 | -1.46 | -1.47 | -1.41 | -1.31 | -1.23 | -1.2 | -1.24 |
EBITDA | 37.65M | 26.76M | 8.55M | 7.62M | 12.87M | -4.31M | -37.15M | -69.85M | -96.55M | -122.95M | -114.74M | -107.61M | -96.69M | -80.19M | -69.56M | -61.84M | -58.83M |
EBIT | 35.96M | 25M | 6.71M | 5.72M | 10.83M | -6.48M | -34.56M | -67.4M | -94.1M | -120.51M | -118.13M | -111.06M | -100.22M | -83.78M | -72.25M | -64.51M | -61.44M |
Depreciation & Amortization | 1.69M | 1.77M | 1.84M | 1.9M | 2.97M | 4M | 5M | 6M | 5.92M | 5.86M | 5.85M | 5.84M | 5.83M | 5.84M | 5.02M | 4.2M | 3.37M |